Diffusing lung capacity and pro-brain natriuretic peptide in patients with limited cutaneous form of systemic sclerosis at risk for pulmonary hypertension

A. Stanziola, A. Parisi, E. Carpentieri, S. Padula, P. Caso, R. Scarpa, M. Sofia (Naples, Italy)

Source: Annual Congress 2010 - Pulmonary circulation I
Session: Pulmonary circulation I
Session type: Thematic Poster Session
Number: 1100
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Stanziola, A. Parisi, E. Carpentieri, S. Padula, P. Caso, R. Scarpa, M. Sofia (Naples, Italy). Diffusing lung capacity and pro-brain natriuretic peptide in patients with limited cutaneous form of systemic sclerosis at risk for pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 1100

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Source: Eur Respir J 2010; 35: 95-104
Year: 2010



N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004

The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007


N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005



Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007


N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003



Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007



Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007


Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


The utility of brain natriuretic peptide in patients with stable chronic lung diseases
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012


The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


Brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005

Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006

Elevated brain natriuretic peptide predicts mortality in interstitial lung disease
Source: Eur Respir J 2010; 36: 819-825
Year: 2010



Association of haemodynamic parameters with circulating natriuretic peptides in precapillary pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006

Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008